Rizvi Syed Ali-aamir 4
4 · Caribou Biosciences, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Rizvi Syed Ali-aamir
Chief Medical Officer
Transactions
- Award
Option to purchase common stock
2022-01-25+161,250→ 161,250 totalExercise: $10.64Exp: 2032-01-24→ Common stock (161,250 underlying) - Award
Common stock
2022-01-25+60,000→ 65,000 total
Footnotes (2)
- [F1]This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on January 18, 2023, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date.
- [F2]1/4th of the shares subject to this option will vest on January 18, 2023 and an additional 1/48th of the aggregate number of shares subject to the option will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.